Cargando…
DNA Damage Repair and Drug Efflux as Potential Targets for Reversing Low or Intermediate Ciprofloxacin Resistance in E. coli K-12
Ciprofloxacin is a potent antibacterial drug that is widely used in human clinical applications. As a consequence of its extensive use, resistance has emerged in almost all clinically relevant bacterial species. A mean to combat the observed ciprofloxacin resistance is by reversing it via co-adminis...
Autores principales: | Klitgaard, Rasmus N., Jana, Bimal, Guardabassi, Luca, Nielsen, Karen L., Løbner-Olesen, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036142/ https://www.ncbi.nlm.nih.gov/pubmed/30013537 http://dx.doi.org/10.3389/fmicb.2018.01438 |
Ejemplares similares
-
Iron chelation increases the tolerance of Escherichia coli to hyper-replication stress
por: Charbon, Godefroid, et al.
Publicado: (2018) -
The Role of Efflux Pumps in the Transition from Low-Level to Clinical Antibiotic Resistance
por: Ebbensgaard, Anna Elisabeth, et al.
Publicado: (2020) -
Oxidative DNA damage is instrumental in hyperreplication stress-induced inviability of Escherichia coli
por: Charbon, Godefroid, et al.
Publicado: (2014) -
In Silico Prediction and Prioritization of Novel Selective Antimicrobial Drug Targets in Escherichia coli
por: Svanberg Frisinger, Frida, et al.
Publicado: (2021) -
DnaC Inactivation in Escherichia coli K-12 Induces the SOS Response and Expression of Nucleotide Biosynthesis Genes
por: Løbner-Olesen, Anders, et al.
Publicado: (2008)